BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 24889900)

  • 1. Genetics: Founder mutations identified in an inherited form of the metabolic syndrome.
    Holmes D
    Nat Rev Endocrinol; 2014 Jul; 10(7):377. PubMed ID: 24889900
    [No Abstract]   [Full Text] [Related]  

  • 2. The metabolic syndrome and DYRK1B.
    Mirshahi T; Murray MF; Carey DJ
    N Engl J Med; 2014 Aug; 371(8):784-5. PubMed ID: 25140973
    [No Abstract]   [Full Text] [Related]  

  • 3. The metabolic syndrome and DYRK1B.
    Keramati AR; Fathzadeh M; Mani A
    N Engl J Med; 2014 Aug; 371(8):785-6. PubMed ID: 25140972
    [No Abstract]   [Full Text] [Related]  

  • 4. The metabolic syndrome and DYRK1B.
    Morita H; Komuro I
    N Engl J Med; 2014 Aug; 371(8):785. PubMed ID: 25140975
    [No Abstract]   [Full Text] [Related]  

  • 5. The metabolic syndrome and DYRK1B.
    He JL; Qiao GF; Li BY
    N Engl J Med; 2014 Aug; 371(8):785. PubMed ID: 25140974
    [No Abstract]   [Full Text] [Related]  

  • 6. DYRK1B variant linked to autosomal dominant metabolic syndrome.
    Hickmott J
    Clin Genet; 2015 Jan; 87(1):30-1. PubMed ID: 25092113
    [No Abstract]   [Full Text] [Related]  

  • 7. A form of the metabolic syndrome associated with mutations in DYRK1B.
    Keramati AR; Fathzadeh M; Go GW; Singh R; Choi M; Faramarzi S; Mane S; Kasaei M; Sarajzadeh-Fard K; Hwa J; Kidd KK; Babaee Bigi MA; Malekzadeh R; Hosseinian A; Babaei M; Lifton RP; Mani A
    N Engl J Med; 2014 May; 370(20):1909-1919. PubMed ID: 24827035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. DYRK1B haploinsufficiency in a family with metabolic syndrome and abnormal cognition.
    Orenstein N; Gofin Y; Shomron N; Ruhrman-Shahar N; Magal N; Hagari O; Azulay N; Bazak L; Goldberg Y; Basel-Salmon L
    Clin Genet; 2022 Feb; 101(2):265-266. PubMed ID: 34786696
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DYRK1B mutations associated with metabolic syndrome impair the chaperone-dependent maturation of the kinase domain.
    Abu Jhaisha S; Widowati EW; Kii I; Sonamoto R; Knapp S; Papadopoulos C; Becker W
    Sci Rep; 2017 Jul; 7(1):6420. PubMed ID: 28743892
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Truncation of the Down syndrome candidate gene DYRK1A in two unrelated patients with microcephaly.
    Møller RS; Kübart S; Hoeltzenbein M; Heye B; Vogel I; Hansen CP; Menzel C; Ullmann R; Tommerup N; Ropers HH; Tümer Z; Kalscheuer VM
    Am J Hum Genet; 2008 May; 82(5):1165-70. PubMed ID: 18405873
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Novel DYRK1A mutations in 2 individuals with autosomal dominant mental retardation-7].
    Zou XM; Xiao H; He HL; Guang SQ; Peng J
    Zhonghua Er Ke Za Zhi; 2019 Oct; 57(10):804-806. PubMed ID: 31594070
    [TBL] [Abstract][Full Text] [Related]  

  • 12. High diagnostic yield of clinically unidentifiable syndromic growth disorders by targeted exome sequencing.
    Kim YM; Lee YJ; Park JH; Lee HD; Cheon CK; Kim SY; Hwang JY; Jang JH; Yoo HW
    Clin Genet; 2017 Dec; 92(6):594-605. PubMed ID: 28425089
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutational analysis of two residues in the DYRK homology box of the protein kinase DYRK1A.
    Widowati EW; Bamberg-Lemper S; Becker W
    BMC Res Notes; 2018 May; 11(1):297. PubMed ID: 29764512
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Founder Ashkenazi Jewish mutations of large deletion in the inherited retinal dystrophy genes.
    Chiang JP; Luo H; Duan J; Ekstein J; Hirsch Y
    Ophthalmic Genet; 2018; 39(1):135-136. PubMed ID: 28726569
    [No Abstract]   [Full Text] [Related]  

  • 15. Dual-specificity protein kinases: will any hydroxyl do?
    Lindberg RA; Quinn AM; Hunter T
    Trends Biochem Sci; 1992 Mar; 17(3):114-9. PubMed ID: 1412695
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genetics of insulin resistance syndrome.
    Stern MP
    Endocr Pract; 2003; 9 Suppl 2():35-8. PubMed ID: 14698973
    [No Abstract]   [Full Text] [Related]  

  • 17. CHEK2 mutation and hereditary breast cancer.
    Bogdanova N; Feshchenko S; Cybulski C; Dörk T
    J Clin Oncol; 2007 Jul; 25(19):e26. PubMed ID: 17602067
    [No Abstract]   [Full Text] [Related]  

  • 18. The contribution of founder mutations to early-onset breast cancer in French-Canadian women.
    Ghadirian P; Robidoux A; Zhang P; Royer R; Akbari M; Zhang S; Fafard E; Costa M; Martin G; Potvin C; Patocskai E; Larouche N; Younan R; Nassif E; Giroux S; Narod SA; Rousseau F; Foulkes WD
    Clin Genet; 2009 Nov; 76(5):421-6. PubMed ID: 19863560
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnosis: A clear answer.
    Sohn E
    Nature; 2016 Sep; 537(7619):S64-5. PubMed ID: 27602744
    [No Abstract]   [Full Text] [Related]  

  • 20. Arg1201Gln mutation of insulin receptor impairs tyrosine kinase activity and causes insulin resistance: a case report.
    Ding Q; Liang M
    Gynecol Endocrinol; 2020 Jun; 36(6):558-560. PubMed ID: 31899992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.